In Silico Discovery of a Small Molecule Suppressing Lung Carcinoma A549 Cells Proliferation and Inducing Autophagy via mTOR Pathway Inhibition

  • Jiyuan Liu
  • , Li Liu
  • , Zhen Tian
  • , Yifan Li
  • , Changhong Shi
  • , Junling Shi
  • , Sanhua Wei
  • , Yong Zhao
  • , Caiqing Zhang
  • , Bing Bai
  • , Zhinan Chen
  • , Hai Zhang

Research output: Contribution to journalArticlepeer-review

9 Scopus citations

Abstract

Mammalian target of rapamycin (mTOR) kinase is vital to the regulation of cell growth and proliferation, and it has been taken as a promising target to develop cancer therapies. By reference to the crystal structure of mTOR-PP242, we explored to discover potential ATP-competitive inhibitors of mTOR. Through the integrated use of multiple in silico screenings, the tremendous amount of compounds from the SPECS database were finally reduced to 30. After several rounds of convincing biological tests in A549 cells, the newfound C-4 was identified as a potential ATP-competitive inhibitor of mTOR. Besides A549 cell proliferation suppression caused by C-4, autophagy was also determined through autophagosome observation and autophagy flux detection in C-4 treated A549 cells. We demonstrated that C-4 could inhibit cell growth and proliferation, and this inhibition may be associated with autophagy.

Original languageEnglish
Pages (from-to)5427-5436
Number of pages10
JournalMolecular Pharmaceutics
Volume15
Issue number11
DOIs
StatePublished - 5 Nov 2018

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • autophagy
  • inhibitor
  • mTOR kinase
  • pharmacophore modeling
  • virtual screening

Fingerprint

Dive into the research topics of 'In Silico Discovery of a Small Molecule Suppressing Lung Carcinoma A549 Cells Proliferation and Inducing Autophagy via mTOR Pathway Inhibition'. Together they form a unique fingerprint.

Cite this